Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
		Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
 - Director, PGY2 Pediatric Pharmacy Residency
 - Director, Pediatric Pharmacotherapy Degree Option
 
Publications & Presentations
- 1.   Whittington L M, Johnson P N, Fliehman D, Hayes K, Taylor S, Van Devender E A, Chan R.  Supporting resident well-being: Considerations for residency program directors and pharmacy enterprise leadership.  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.  2025;  82 : e915-e920
 
2. Moore B, Johnson P N, Miller J L. A Structured Approach to Identifying and Addressing Drug Therapy Problems in Neonatal and Pediatric Critically Ill Patients: IN-DEPTH. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 696-704
3. McLarty T, Miller J L, Lewis T V, Neely S, Johnson P N. Evaluation of Research and Scholarship Activities with a Pediatric Curricular Track in a Doctor of Pharmacy Program. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 607-616
4. Sikora A, Murray B, Henry K, Smith S, Buckley M, Campbell R, Dixit D, Dzierba A, Haas C, Heavner M, Heavner J, Iademarco M, Jew R, Johnson P N, Kane-Gill S, Martin G, Palm N, Reed B, Seckel M, Steffenhagen A, Smith Z. Consensus recommendations for the integration of critical care pharmacists on intensive care unit teams: Endorsed by the American Association of Critical-Care Nurses, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2025; 8 : 914–930
5. Johnson P N, Ropp D L, Ranallo C, Chaaban H, Garcia-Contreras L, Neely S, Miller J L. Inhaled Tobramycin Usage in Critically Ill Pediatric Patients Without Cystic Fibrosis: A Pediatric Pharmacy-Association, Practice-Based Research Network Survey Study. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 332-339
Grants
-                                                                                         1.   Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity.  Misc Non-Federal. Start Date: 2020.  End Date: 2021.  
 
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
-                                                                                         1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Avery Parman). Date: 2024.  
 
2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.
3. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.
4. Society of Critical Care Medicine Presidential Citation. Date: 2022.
5. Oklahoma Foundation for Excellence. Oklahoma Medal for Excellence Finalist in Teaching and Administration. Date: 2022.
Education
-                                                                                         1.  Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.  
 
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results